Cargando…
Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy
INTRODUCTION: Image-based early detection for diabetic retinopathy (DR) needs value addition due to lack of well-defined disease-specific quantitative imaging biomarkers (QIBs) for neuroretinal degeneration and spectropathological information at the systemic level. Retinal neurodegeneration is an ea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703157/ https://www.ncbi.nlm.nih.gov/pubmed/29200821 http://dx.doi.org/10.2147/OPTH.S140110 |
_version_ | 1783281649235001344 |
---|---|
author | Guha Mazumder, Arpan Chatterjee, Swarnadip Chatterjee, Saunak Gonzalez, Juan Jose Bag, Swarnendu Ghosh, Sambuddha Mukherjee, Anirban Chatterjee, Jyotirmoy |
author_facet | Guha Mazumder, Arpan Chatterjee, Swarnadip Chatterjee, Saunak Gonzalez, Juan Jose Bag, Swarnendu Ghosh, Sambuddha Mukherjee, Anirban Chatterjee, Jyotirmoy |
author_sort | Guha Mazumder, Arpan |
collection | PubMed |
description | INTRODUCTION: Image-based early detection for diabetic retinopathy (DR) needs value addition due to lack of well-defined disease-specific quantitative imaging biomarkers (QIBs) for neuroretinal degeneration and spectropathological information at the systemic level. Retinal neurodegeneration is an early event in the pathogenesis of DR. Therefore, development of an integrated assessment method for detecting neuroretinal degeneration using spectropathology and QIBs is necessary for the early diagnosis of DR. METHODS: The present work explored the efficacy of intensity and textural features extracted from optical coherence tomography (OCT) images after selecting a specific subset of features for the precise classification of retinal layers using variants of support vector machine (SVM). Fourier transform infrared (FTIR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy were also performed to confirm the spectropathological attributes of serum for further value addition to the OCT, fundoscopy, and fluorescein angiography (FA) findings. The serum metabolomic findings were also incorporated for characterizing retinal layer thickness alterations and vascular asymmetries. RESULTS: Results suggested that OCT features could differentiate the retinal lesions indicating retinal neurodegeneration with high sensitivity and specificity. OCT, fundoscopy, and FA provided geometrical as well as optical features. NMR revealed elevated levels of ribitol, glycerophosphocholine, and uridine diphosphate N-acetyl glucosamine, while the FTIR of serum samples confirmed the higher expressions of lipids and β-sheet-containing proteins responsible for neoangiogenesis, vascular fragility, vascular asymmetry, and subsequent neuroretinal degeneration in DR. CONCLUSION: Our data indicated that disease-specific spectropathological alterations could be the major phenomena behind the vascular attenuations observed through fundoscopy and FA, as well as the variations in the intensity and textural features observed in OCT images. Finally, we propose a model that uses spectropathology corroborated with specific QIBs for detecting neuroretinal degeneration in early diagnosis of DR. |
format | Online Article Text |
id | pubmed-5703157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57031572017-11-30 Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy Guha Mazumder, Arpan Chatterjee, Swarnadip Chatterjee, Saunak Gonzalez, Juan Jose Bag, Swarnendu Ghosh, Sambuddha Mukherjee, Anirban Chatterjee, Jyotirmoy Clin Ophthalmol Original Research INTRODUCTION: Image-based early detection for diabetic retinopathy (DR) needs value addition due to lack of well-defined disease-specific quantitative imaging biomarkers (QIBs) for neuroretinal degeneration and spectropathological information at the systemic level. Retinal neurodegeneration is an early event in the pathogenesis of DR. Therefore, development of an integrated assessment method for detecting neuroretinal degeneration using spectropathology and QIBs is necessary for the early diagnosis of DR. METHODS: The present work explored the efficacy of intensity and textural features extracted from optical coherence tomography (OCT) images after selecting a specific subset of features for the precise classification of retinal layers using variants of support vector machine (SVM). Fourier transform infrared (FTIR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy were also performed to confirm the spectropathological attributes of serum for further value addition to the OCT, fundoscopy, and fluorescein angiography (FA) findings. The serum metabolomic findings were also incorporated for characterizing retinal layer thickness alterations and vascular asymmetries. RESULTS: Results suggested that OCT features could differentiate the retinal lesions indicating retinal neurodegeneration with high sensitivity and specificity. OCT, fundoscopy, and FA provided geometrical as well as optical features. NMR revealed elevated levels of ribitol, glycerophosphocholine, and uridine diphosphate N-acetyl glucosamine, while the FTIR of serum samples confirmed the higher expressions of lipids and β-sheet-containing proteins responsible for neoangiogenesis, vascular fragility, vascular asymmetry, and subsequent neuroretinal degeneration in DR. CONCLUSION: Our data indicated that disease-specific spectropathological alterations could be the major phenomena behind the vascular attenuations observed through fundoscopy and FA, as well as the variations in the intensity and textural features observed in OCT images. Finally, we propose a model that uses spectropathology corroborated with specific QIBs for detecting neuroretinal degeneration in early diagnosis of DR. Dove Medical Press 2017-11-22 /pmc/articles/PMC5703157/ /pubmed/29200821 http://dx.doi.org/10.2147/OPTH.S140110 Text en © 2017 Guha Mazumder et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Guha Mazumder, Arpan Chatterjee, Swarnadip Chatterjee, Saunak Gonzalez, Juan Jose Bag, Swarnendu Ghosh, Sambuddha Mukherjee, Anirban Chatterjee, Jyotirmoy Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy |
title | Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy |
title_full | Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy |
title_fullStr | Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy |
title_full_unstemmed | Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy |
title_short | Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy |
title_sort | spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703157/ https://www.ncbi.nlm.nih.gov/pubmed/29200821 http://dx.doi.org/10.2147/OPTH.S140110 |
work_keys_str_mv | AT guhamazumderarpan spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy AT chatterjeeswarnadip spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy AT chatterjeesaunak spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy AT gonzalezjuanjose spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy AT bagswarnendu spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy AT ghoshsambuddha spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy AT mukherjeeanirban spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy AT chatterjeejyotirmoy spectropathologycorroboratedmultimodalquantitativeimagingbiomarkersforneuroretinaldegenerationindiabeticretinopathy |